The Massachusetts attorney general’s office is investigating whether Gilead Sciences Inc.’s pricing of its hepatitis C drugs is unlawful, according to a letter from the prosecutor that also asked the company to lower its prices.
from WSJ.com: US Business http://ift.tt/1noGmgU
via IFTTT
No comments:
Post a Comment